The clinical evaluation of biofiltration

Area of Science:

• Nephrology
• Biomedical Engineering
• Clinical Medicine

Background:

• Biofiltration (BF) is a treatment modality for patients with end-stage renal failure.
• Evaluating the clinical effectiveness of BF is crucial for optimizing renal replacement therapy.

Purpose of the Study:

• To assess the efficacy of biofiltration in patients undergoing treatment for terminal renal failure.
• To compare the outcomes of biofiltration with conventional hemodialysis.

Main Methods:

• Clinical evaluation of biofiltration in patients with terminal renal failure.
• Monitoring hypotensive episodes during biofiltration treatment.
• Assessing patient subjective well-being during the interdialysis period.

Main Results:

• No significant reduction in hypotensive episodes was observed during biofiltration.
• Biofiltration allows for a reduced duration of the dialysis procedure, which may benefit certain patient groups.
• Patients reported a better subjective feeling during the interdialysis period with biofiltration compared to conventional hemodialysis.

Conclusions:

• Biofiltration may not reduce hypotensive episodes in patients with end-stage renal failure.
• The shortened dialysis time and improved interdialysis well-being are potential advantages of biofiltration for select patients.
• Further research may be warranted to explore the full clinical utility of biofiltration in renal replacement therapy.